1.69
Macrogenics Inc Aktie (MGNX) Neueste Nachrichten
Technical Models Detect Momentum Build in MacroGenics Inc.July 2025 Reactions & Stock Portfolio Risk Control - classian.co.kr
Elliott Wave Theory Predicts Pullback in MacroGenics Inc.July 2025 Outlook & Consistent Growth Equity Picks - classian.co.kr
MacroGenics Inc. Breakout Confirmed by Volume MetricsPortfolio Return Report & AI Driven Stock Movement Reports - thegnnews.com
DC InnoMacroGenics strikes potential $1.7B deal with Gilead | Quantum Computing is expanding - The Business Journals
Is it too late to sell MacroGenics Inc.Earnings Growth Summary & Weekly Chart Analysis and Guides - Newser
What to expect from MacroGenics Inc. in the next 30 daysEarnings Risk Report & Consistent Profit Focused Trading Strategies - Newser
Can MacroGenics Inc. grow without dilution2025 Growth vs Value & Verified Short-Term Trading Plans - thegnnews.com
MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
What candlestick patterns are forming on MacroGenics Inc.Gap Up & Risk Controlled Stock Alerts - Newser
What the charts say about MacroGenics Inc. todayWeekly Trade Analysis & Reliable Entry Point Alerts - Newser
Is MacroGenics Inc. stock ready for a breakoutJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser
Is now a turning point for MacroGenics Inc.Quarterly Portfolio Summary & Low Volatility Stock Recommendations - Newser
Leerink Partners Has Lowered Expectations for MacroGenics (NASDAQ:MGNX) Stock Price - Defense World
Will MacroGenics Inc. see short term momentumMarket Activity Summary & Consistent Profit Focused Trading Strategies - Newser
Why MacroGenics Inc. stock attracts strong analyst attention2025 Stock Rankings & Real-Time Chart Pattern Alerts - Newser
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates - MSN
MacroGenics price target lowered to $5 from $8 at Leerink - MSN
Rockville’s MacroGenics Appoints New President/CEO For First Time in 24 Years - The MoCo Show -
MacroGenics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
How MacroGenics Inc. stock performs during market volatilityEarnings Beat & Community Supported Trade Ideas - Newser
Macrogenics, Inc. shares fall 1.27% after-hours following Johnson & Johnson's presentation at BofA Securities 2025. - AInvest
MacroGenics appoints Eric Risser as CEO as Scott Koenig exits - The Business Journals
Macrogenics: Leerink Partners lowers PT to $5, maintains Outperform rating. - AInvest
MacroGenics' CEO Transition and Lorigerlimab Trial Uncertainty Warrant Hold Rating Amid Partnership Exploration - AInvest
MacroGenics Price Target Lowered to $5 at Leerink - AInvest
MacroGenics Inc. Reports Q2 2025 Financial Results - MSN
Macrogenics 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
MacroGenics stock maintains Market Perform rating at Citizens JMP By Investing.com - Investing.com Canada
MacroGenics: Q2 Earnings Snapshot - Greenwich Time
MacroGenics (MGNX): Strategic Transition, Pipeline Progress, and Liquidity Outlook for Biotech Investors - AInvest
Macrogenics Inc (MGNX) Q2 2025 Earnings: EPS of -$0.57 Beats Est - GuruFocus
MacroGenics appoints new CEO - MSN
MacroGenics Slows Its Losses And Adds $70 Million To The Bank - Finimize
MacroGenics reports Q2 EPS (57c), consensus (38c) - TipRanks
MacroGenics Revenue Doubles in Q2 - The Globe and Mail
MacroGenics Appoints Eric Risser as New CEO - The Globe and Mail
MacroGenics Inc earnings missed by $0.11, revenue fell short of estimates - Investing.com Nigeria
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities - GlobeNewswire
MacroGenics Reports Q2 2025 Financials, Updates Key Strategic Priorities - AInvest
MacroGenics Extends Cash Runway to 2027 with $70M Royalty Deal as New CEO Unveils Strategic Roadmap - Stock Titan
MacroGenics Inc. Approaches Psychological Resistance LevelJuly 2025 Volume & Advanced Swing Trade Entry Alerts - classian.co.kr
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors? - TipRanks
MacroGenics promotes Eric Risser to president and CEO - The Pharma Letter
MacroGenics' Leadership Transition: A Strategic Inflection Point for Capital Efficiency and Growth - AInvest
Short Term Charts Align With Long Term Uptrend in MacroGenics Inc.July 2025 Intraday Action & Weekly Market Pulse Updates - beatles.ru
MacroGenics Appoints Eric Risser As CEO - MarketScreener
MacroGenics names Eric Risser as new CEO, succeeding Scott Koenig By Investing.com - Investing.com Nigeria
MacroGenics appoints Eric Risser as new CEO, succeeding Scott Koenig By Investing.com - Investing.com Nigeria
MacroGenics names Eric Risser as new CEO, succeeding Scott Koenig - Investing.com India
MacroGenics Appoints Eric Risser as President and Chief Executive Officer | MGNX Stock News - GuruFocus
MacroGenics appoints Eric Risser as new CEO, succeeding Scott Koenig - Investing.com
MacroGenics Appoints Eric Risser as President and Chief Executive Officer - GlobeNewswire
MacroGenics, Inc. Announces Chief Executive Officer Changes, Effective August 13, 2025 - MarketScreener
Using Ichimoku Cloud for MacroGenics Inc. technicalsFree Watchlist for Smart Swing Trading - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):